Table 4.
Follow-up DXA measurement of 5 Chinese patients with hypophosphatemia osteomalacia induced by low-dose adefovir therapy
| Region | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | |
|---|---|---|---|---|---|---|
| L1-4 | BMD (g/cm2) | 0.855 | 0.725 | 1.070 | 1.466 | 1.037 |
| T-score | –3.0 | –3.8 | –1.2 | 2.0 | –0.8 | |
| Z-score | –2.1 | –2.3 | –0.8 | 3.3 | 0.7 | |
| Femoral neck | BMD | 0.694 | 0.601 | 1.013 | 1.053 | 0.742 |
| T-score | –2.9 | –3.1 | –0.4 | –0.1 | –2.1 | |
| Z-score | –1.7 | –1.7 | 0.7 | 1.4 | –0.4 | |
| Total hip | BMD | 0.680 | 0.554 | 0.920 | 0.883 | 0.846 |
| T-score | –2.9 | –3.6 | –0.1 | –1.5 | –1.3 | |
| Z-score | –2.1 | –2.5 | 0.4 | –0.5 | 0.2 |
Abbreviations: DXA, dual X-ray absorptiometry; BMD, bone mineral density.